EN | RU
EN | RU

Help Support

Back

Pediatric endoscopic pilonidal sinus therapy found beneficial for pilonidal sinus disease

Pediatric endoscopic pilonidal sinus therapy found beneficial for pilonidal sinus disease Pediatric endoscopic pilonidal sinus therapy found beneficial for pilonidal sinus disease
Pediatric endoscopic pilonidal sinus therapy found beneficial for pilonidal sinus disease Pediatric endoscopic pilonidal sinus therapy found beneficial for pilonidal sinus disease

What's new?

Pediatric endoscopic pilonidal sinus treatment can be regarded as the standard of care for invasive treatment of pilonidal sinus disease in children and adolescents. 

As per a recent retrospective review issued in Updates in Surgery, Pediatric endoscopic pilonidal sinus treatment (PEPSiT) was considered as an easy procedure with a short and painless postoperative course and a low rate of recurrence in pilonidal sinus disease (PSD) patients aged less than 18 years. The standardized treatment protocol, accurate patient enrollment, and information, and thorough follow-up contributed to the effectiveness of this treatment.

This review by Ciro Esposito et al. described the tips and tricks of the PEPSiT and its experience over 3 years. The patients with primary or recurrent PSD, undertaking PEPSiT were included. These patients were given laser therapy before the operation, PEPSiT and post-surgery dressing, and laser therapy. Assessment of success rate, healing rate as per time, post-surgery management, short- and long-term outcome, and satisfaction of the patient was done.

Out of the total 152 patients, 15 patients (9.8%) had a recurrent PSD. Following the operation, the patients resumed their routine activities after a day. All the patients experienced a painless post-operative course (Visual Analogue Scale [VAS] pain score <2) with exceptional patient satisfaction. About 95.4% of patients reported complete resolution of symptoms in 8 weeks with a median healing time of 24.6 days.

As per Clavien's classification of complications, immediate grade 2 (3 oedema and 2 burns) and delayed grade 2 (3 granulomas and 8 wound infections) complications were witnessed in 5 (3.3%) and 11 patients (7.2%), respectively after the surgery. Also, 4.6% of patients were re-operated using PEPSiT due to disease recurrence. Thus, PEPSiT is a valuable standard of care for surgical therapy of PSD in children and teenagers.

Source:

Updates in Surgery

Article:

Pediatric endoscopic pilonidal sinus treatment (PEPSiT): what we learned after a 3-year experience in the pediatric population

Authors:

Ciro Esposito et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: